KKR is paying $5.7bn for a medical-device company patients rarely see. Here is why Integer matters
KKR has agreed to acquire Integer Holdings in a $5.7 billion transaction, taking one of the world’s largest medical-device development and manufacturing partners private. The deal gives KKR exposure to cardiovascular, neuromodulation and cardiac-rhythm technologies, but Integer’s slowing sales and elevated debt show why operational execution will matter after the takeover.
